I agree that this site is using cookies. You can find further informations here.
X
Villasboas, J.C.
383  results:
Search for persons X
?
1

COORDINATED CHANGES IN THE TUMOR MICROENVIRONMENT (TME) ARE..:

Soekojo, C. Y. ; Whitaker, K. R. ; Ferre, R. Leon...
Hematological Oncology.  41 (2023)  S2 - p. 226-227 , 2023
Link: https://doi.org/10.1002/..
 
?
2

Clinical advances in epigenetic therapies for lymphoma:

Rosenthal, Allison C. ; Munoz, Javier L. ; Villasboas, J. C.
Clinical Epigenetics.  15 (2023)  1 - p. , 2023
Link: https://doi.org/10.1186/..
 
?
3

Characterization of the tumor microenvironment in classic H..:

Niu, A. ; Whitaker, K. ; Soekojo, C. Y....
Hematological Oncology.  41 (2023)  S2 - p. 266-267 , 2023
Link: https://doi.org/10.1002/..
 
?
4

Final Result of DIAL (NCI10089), Randomized Phase 2 trial o..:

Soekojo, C. Y. ; Yin, J. ; Kline, J....
Hematological Oncology.  41 (2023)  S2 - p. 592-594 , 2023
Link: https://doi.org/10.1002/..
 
?
5

ODRONEXTAMAB IN PATIENTS WITH RELAPSED/REFRACTORY FOLLICULA..:

Novelli, S. ; Luminari, S. ; Taszner, M....
Hematological Oncology.  41 (2023)  S2 - p. 121-122 , 2023
Link: https://doi.org/10.1002/..
 
?
6

The Immunobiology of histologic transformation in follicula..:

Soekojo, C. Y. ; Whitaker, K. R. ; Ferre, R. Leon..
Hematological Oncology.  41 (2023)  S2 - p. 261-262 , 2023
Link: https://doi.org/10.1002/..
 
?
7

P1115: A MULTICENTER PHASE 1/2 TRIAL OF EO2463, A MICROBIAL..:

Zinzani, P. L. ; Ansell, S. M. ; Bosch, F....
HemaSphere.  6 (2022)  - p. 1005-1006 , 2022
Link: https://doi.org/10.1097/..
 
?
8

IMPACT OF TIME TO RELAPSE AND RESPONSE TO SALVAGE THERAPY O..:

Tun, A. M ; Wang, Y ; Maliske, S...
Hematological Oncology.  39 (2021)  S2 - p. , 2021
Link: https://doi.org/10.1002/..
 
?
9

Patterns of therapy initiation during the first decade for ..:

Arushi Khurana ; Mwangi, Raphael ; Ansell, Stephen M....
Blood Cancer Journal.  11 (2021)  7 - p. , 2021
Link: https://doi.org/10.1038/..
 
?
10

Antibody Therapy in Follicular Lymphoma:

, In: Follicular Lymphoma,
Villasboas, J. C. ; Nowakowski, Grzegorz S. - p. 189-206 , 2019
Link: https://doi.org/10.1007/..
 
?
11

Optimization of a Functional T Cell Panel for Mass Cytometr:

Schoon, Hannah ; Villasboas, J.C. ; Krull, Jordan.
The FASEB Journal.  33 (2019)  S1 - p. , 2019
Link: https://doi.org/10.1096/..
 
?
12

THE DIAL STUDY (DUAL IMMUNOMODULATION IN AGGRESSIVE LYMPHOM..:

Villasboas, J.C. ; Reeder, C.B. ; Tun, H.W....
Hematological Oncology.  37 (2019)  S2 - p. 70-71 , 2019
Link: https://doi.org/10.1002/..
 
?
13

EXPRESSION OF LAG‐3 DEFINES EXHAUSTION OF INTRATUMORAL PD‐1..:

Yang, Z. ; Kim, H. ; Villasboas, J.C....
Hematological Oncology.  35 (2017)  S2 - p. 260-261 , 2017
Link: https://doi.org/10.1002/..
 
?
14

Prognostic Factors for Locoregional Recurrence in HER-2 Ove..:

Arsenault, D.M. ; Hurley, J. ; Reis, I....
International Journal of Radiation Oncology*Biology*Physics.  81 (2011)  2 - p. S225 , 2011
Link: https://doi.org/10.1016/..
 
?
15

Native Conditional iswap Operation with Superconducting Art..:

Hu, Chang-Kang ; Yuan, Jiahao ; Veloso, Bruno A....
Physical Review Applied.  20 (2023)  3 - p. , 2023
Link: https://doi.org/10.1103/..
 
1-15